Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma

Medical Oncology ◽

10.1007/s12032-017-0918-1 ◽

2017 ◽

Vol 34 (4) ◽

Author(s):

Wiktoria Blaszczak ◽

Wojciech Barczak ◽

Anna Wegner ◽

Wojciech Golusinski ◽

Wiktoria Maria Suchorska

Keyword(s):

Squamous Cell Carcinoma ◽

Monoclonal Antibodies ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma ◽

Download Full-text

Tyrosine kinase inhibitors in head and neck squamous cell carcinoma – a therapeutic chance?

10.1055/s-0041-1727986 ◽

2021 ◽

Author(s):

A Lammert ◽

A Affolter ◽

J Heid ◽

Y Jakob ◽

F Jungbauer ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma

Download Full-text

EGFR tyrosine kinase inhibitors differentially affect autophagy in head and neck squamous cell carcinoma

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2017.03.157 ◽

2017 ◽

Vol 486 (4) ◽

pp. 1027-1033 ◽

Author(s):

Jinyang Cai ◽

Ming Sun ◽

Xin Ge ◽

Yue Sun

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

Expert Review of Anticancer Therapy ◽

10.1586/era.12.91 ◽

2012 ◽

Vol 12 (9) ◽

pp. 1149-1159 ◽

Author(s):

Ana Markovic ◽

Christine H Chung

Keyword(s):

Squamous Cell Carcinoma ◽

Monoclonal Antibodies ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Egf Receptor ◽

Download Full-text

Inhibition of integrin mediated cell adhesion of human head and neck squamous cell carcinoma to extracellular matrix laminin by monoclonal antibodies

International Journal of Oncology ◽

10.3892/ijo.11.3.457 ◽

1997 ◽

Author(s):

C vanWaes ◽

D Surh ◽

Z Chen ◽

T Carey

Keyword(s):

Extracellular Matrix ◽

Squamous Cell Carcinoma ◽

Monoclonal Antibodies ◽

Cell Adhesion ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma

Download Full-text

Biological role and clinical value of miR‐99a‐5p in head and neck squamous cell carcinoma ( HNSCC ): A bioinformatics‐based study

FEBS Open Bio ◽

10.1002/2211-5463.12478 ◽

2018 ◽

Vol 8 (8) ◽

pp. 1280-1298 ◽

Author(s):

Yu‐ting Chen ◽

Jian‐ni Yao ◽

Yu‐tao Qin ◽

Kai Hu ◽

Fang Wu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Biological Role ◽

Download Full-text

Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-18-1274 ◽

2019 ◽

Vol 19 (2) ◽

pp. 614-626 ◽

Author(s):

Lluís Nisa ◽

Paola Francica ◽

Roland Giger ◽

Matúš Medo ◽

Olgun Elicin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Receptor Tyrosine Kinase ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Met Receptor ◽

Met Receptor Tyrosine Kinase

Download Full-text

The effect of selective tyrosine kinase inhibitors on the expression of HIF1α and mTOR in p16-positive and -negative squamous cell carcinoma (HNSCC)

10.1055/s-0038-1640071 ◽

2018 ◽

Author(s):

B Kramer ◽

B Kuhlin ◽

N Rotter ◽

C Aderhold

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors

Download Full-text

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV+ and HPV− Squamous Cell Carcinoma

Cancer Genomics & Proteomics ◽

10.21873/cgp.20214 ◽

2020 ◽

Vol 17 (5) ◽

pp. 579-585

Author(s):

BENJAMIN KANSY ◽

CHRISTOPH ADERHOLD ◽

LENA HUBER ◽

SONJA LUDWIG ◽

RICHARD BIRK ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Expression Patterns

Download Full-text

Faculty Opinions recommendation of The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164509.626273 ◽

2009 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Receptor Tyrosine Kinase ◽

Therapeutic Target ◽

Neck Squamous Cell Carcinoma ◽

Met Receptor Tyrosine Kinase ◽

Novel Therapeutic

Download Full-text

Abstract B07: Potential clinical value of methylated microRNAs in saliva-liquid biopsy for surveillance of head and neck squamous cell carcinoma

10.1158/1557-3265.liqbiop20-b07 ◽

2020 ◽

Author(s):

Ling Lv ◽

Steve Quattlebaum ◽

Dexiang Gao ◽

Yu Cao ◽

Ben Milam ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Liquid Biopsy ◽

Neck Squamous Cell Carcinoma ◽

Download Full-text